Serpenta Email Formats
Medical Equipment Manufacturing • 
London, England, United Kingdom • 1-10 Employees
Key Contact at Serpenta
Arnau Garriga Casanovas
CEO and Co-Founder
Company overview
| Headquarters | Euston House, 24 Eversholt Street, London, NW1 1AD, GB |
| NAICS | 3391 |
| Keywords | Medical Devices, Robotics, Machine Learning, Med-Tech, Endoluminal Surgery |
| Founded | 2024 |
| Employees | 1-10 |
About Serpenta
We are a deeptech company developing medical robots for endoluminal surgery in the lower GI. We specialise in soft and continuum robots with fluidic actuation, which we believe will be the future of surgery. Our core product, under development, is a bi-manual snake-robot for colorectal cancer treatment. We aim to enable endoluminal procedures such as endoscopic submucosal dissection (ESD) to be performed at a large scale with high precision and low risk thanks to our advanced technology. Our robot is based on a design created and patented by our CTO during his doctorate at Imperial College London. This is now being expanded and further developed to create a full robotic device that will enable high precision and dextrous surgery anywhere in the colon with highly flexible transmission lines. Our vision is to revolutionise lower GI surgery leading to lower risk, lower cost, and better patient outcomes. We are a start-up with private investment in a growth phase.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Serpenta has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Serpenta has never raised funding before.
Canada
Australia
France
United States
BelgiumFrequently asked questions
4.8
40,000 users
